Cabaletta Bio, Inc.·4

Oct 18, 9:50 PM ET

Nichtberger Steven 4

4 · Cabaletta Bio, Inc. · Filed Oct 18, 2022

Insider Transaction Report

Form 4
Period: 2022-10-18
Nichtberger Steven
DirectorPresident & CEO
Transactions
  • Purchase

    Common Stock

    2022-10-18$0.99/sh+141,873$141,008978,356 total
Holdings
  • Common Stock

    (indirect: By Trust)
    363,000
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased at prices ranging from $0.9473 to $1.00, inclusive. The reporting person has provided to the Issuer, and undertakes to provide any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F2]The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION